Patrick Burnett has served as Arcutis’ chief medical officer since August 2020. Prior to that, Dr Burnett was the chief medical officer at Verrica Pharmaceuticals since April 2018. Prior to that, Dr Burnett was at Sun Pharmaceuticals where he was associate vice president of clinical development from September 2015 to March 2018, with oversight of the dermatology and rheumatology pipeline. Prior to Sun, Dr Burnett was at Novartis from 2010 to August 2015, most recently as global program medical director. He is a board-certified dermatologist and was a member of the medical faculty at Vanderbilt University Medical Center as an assistant professor of dermatology from 2004 to 2010. Dr Burnett holds an MD and PhD in neuroscience from Johns Hopkins School of Medicine and a BS in biology and biochemistry from the University of Iowa.